Ying Tam, Ph.D.Chief Scientific Officer at Acuitas Therapeutics
Dr. Tam obtained his M.Sc. and Ph.D. University of Waterloo, Canada. He has held several senior academic and industry positions including being one of the founding scientists of Acuitas Therapeutics in 2009. He is now Chief Scientific Officer at Acuitas, a company with a leadership position in the development and application of lipid nanoparticle (LNP) technology for delivery of nucleic acid therapeutics, in particular, messenger RNA therapeutics. Dr. Tam has over 60 publications in peer-reviewed journals relating to LNP technology and development of pharmaceutical products.